Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes
Authors
Keywords
-
Journal
REVIEWS IN MEDICAL VIROLOGY
Volume 30, Issue 2, Pages -
Publisher
Wiley
Online
2019-12-17
DOI
10.1002/rmv.2095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defective Epstein–Barr virus in chronic active infection and haematological malignancy
- (2019) Yusuke Okuno et al. Nature Microbiology
- Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
- (2019) Keisuke Kataoka et al. LEUKEMIA
- Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
- (2019) Masataka Ishimura et al. Frontiers in Pediatrics
- Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells
- (2019) Rémy Rodriguez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
- (2019) Christian Münz NATURE REVIEWS MICROBIOLOGY
- Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma
- (2018) Hiroshi Higuchi et al. BLOOD
- Pathobiologic Roles of Epstein–Barr Virus-Encoded MicroRNAs in Human Lymphomas
- (2018) Mohsen Navari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection
- (2018) Natsuno Konishi et al. mSphere
- The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
- (2018) Abigail Morales-Sánchez et al. Cancers
- Frequent Mutations in Natural Killer/T Cell Lymphoma
- (2018) Yanjie Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Contribution of the KSHV and EBV lytic cycles to tumourigenesis
- (2018) Oliver Manners et al. Current Opinion in Virology
- Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
- (2018) Rou-Jun Peng et al. LEUKEMIA
- How we treat chronic active Epstein–Barr virus infection
- (2017) Akihisa Sawada et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Chronic Active Epstein–Barr Virus Disease
- (2017) Hiroshi Kimura et al. Frontiers in Immunology
- FrequentBCORaberrations in extranodal NK/T-Cell lymphoma, nasal type
- (2016) Akito Dobashi et al. GENES CHROMOSOMES & CANCER
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase
- (2015) XueQiao Liu et al. JOURNAL OF VIROLOGY
- Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
- (2015) Lu Jiang et al. NATURE GENETICS
- Integrated molecular analysis of adult T cell leukemia/lymphoma
- (2015) Keisuke Kataoka et al. NATURE GENETICS
- Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice
- (2015) Christopher B. Whitehurst et al. mBio
- The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells
- (2015) Xiaochen Lin et al. PLoS Pathogens
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Epigenetic regulation of EBV persistence and oncogenesis
- (2014) Italo Tempera et al. SEMINARS IN CANCER BIOLOGY
- Genetics of Epstein–Barr virus microRNAs
- (2014) Olaf Klinke et al. SEMINARS IN CANCER BIOLOGY
- Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation
- (2014) Takuto Ito et al. Cancer Medicine
- Switching of EBV cycles between latent and lytic states
- (2013) Takayuki Murata et al. REVIEWS IN MEDICAL VIROLOGY
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
- (2012) Robert E. White et al. JOURNAL OF CLINICAL INVESTIGATION
- The pathological roles of BART miRNAs in nasopharyngeal carcinoma
- (2012) Angela K-F Lo et al. JOURNAL OF PATHOLOGY
- Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus
- (2012) X. Yu et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
- (2012) S.-D. Ma et al. JOURNAL OF VIROLOGY
- EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
- (2011) H. Kimura et al. BLOOD
- Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008
- (2009) J. I. Cohen et al. ANNALS OF ONCOLOGY
- Phosphorylation of p27Kip1by Epstein-Barr Virus Protein Kinase Induces Its Degradation through SCFSkp2Ubiquitin Ligase Actions during Viral Lytic Replication
- (2009) Satoko Iwahori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway
- (2008) J.-T. Wang et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started